VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
HomeNewsAurobindopharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Top buy and sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

    Prakash Gaba of prakashgaba.com recommends buying Eicher Motors with target at Rs 21,500 and stop loss at Rs 20,000, United Spirits with target at Rs 555 and stop loss at Rs 532 and UltraTech Cement with target at Rs 4,200 and stop loss at Rs 4,050.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Hindustan Petroleum Corporation with a stop loss of Rs 270, target of Rs 284 and Can Fin Homes with a stop loss of Rs 323, target of Rs 341.

  • Podcast | Stock Picks of the Day: 'Banking and financials likely to outperform'

    The Nifty50 should hold above 11,100 for further surge while 10,950-10,800 would act as a cushion in case of any decline.

  • Top buy and sell ideas by Sudarshan Sukhani, Mitessh Thakkar, Prakash Gaba for short term

    Sudarshan Sukhani of s2analytics.com recommends buying Hindustan Unilever with stop loss at Rs 1700 and target of Rs 1735, Dabur India with stop loss at Rs 436 and target of Rs 448 and DCB Bank with stop loss at Rs 195 and target of Rs 204.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends selling HDFC Bank below Rs 2082 with stop loss of Rs 2096 and target of Rs 2055 and Hindustan Unilever below Rs 1730 with stop loss of Rs 1742 for target of Rs 1705.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying UltraTech Cement with a stop loss Rs 3700, target of Rs 3765, Infosys with a stop loss of Rs 748, target of Rs 770 and Maruti Suzuki with a stop loss of Rs 6800, target of Rs 7200.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Sun TV Network with a stop loss of Rs 550, target of Rs 575 and Power Finance Corporation with a stop loss of Rs 104, target of Rs 116.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Titan Company with a stop loss of Rs 1055, target of Rs 1100, Manappuram Finance with a stop loss of Rs 100, target of Rs 112 and Sun Pharma with a stop loss of Rs 430, target of Rs 455.

  • Analysts remain positive on Aurobindo Pharma, expect stock to return 8-30% after Q3 earnings

    Aurobindo has maintained its guidance of 30 percent YoY growth in injectable sales. Further, company filed 10 ANDAs, including 4 injectables, taking the cumulative ANDAs pending for approval to 122

  • Technical View | Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Bharti Infratel with a stop loss of Rs 293, target of Rs 307, NIIT Tech with a stop loss of Rs 1295, target of Rs 1340 and Mindtree with a stop loss of Rs 897, target of Rs 920.

  • Technical View | Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying Amara Raja Batteries with stop loss of Rs 770 and target of Rs 805, Dr Reddy's Labs with a stop loss of Rs 2619 and target of Rs 2700 and Wipro with a stop loss below Rs 340 for target of Rs 360.

  • 2019 to be a good year for mid-smallcaps; 15 picks by Equirus could return 5-93%

    Equirus Securities said uncertainty regarding elections in 2019 might keep markets volatile.

  • Technical Views | Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com advises buying ICICI Bank with a stoploss of Rs 355 and target of Rs 368.

  • Stock-specific play: Brokerages bet on 15 companies for 10-44% returns in 2019

    Mayuresh Joshi of Angel Broking said the year 2019 will largely be a year of stock-specific stories.

  • Technical Views | Top buy & sell ideas by Sudarshan Sukhani, Mitessh Thakkar, Prakash Gaba for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying Cummins India with a stop loss of Rs 812.5 and target of Rs 865, Mahanagar Gas with a stop loss of Rs 875 and target of Rs 950 and Power Grid with a stop loss of Rs 188 and target of Rs 202.

  • Nifty to trade in narrow range; 4 stocks that can give double-digit returns

    On the option front, 10,000 put option strike price is still holding a highest cumulative open interest followed by 10,500 strike price which is suggesting any fall is likely to be bought into

  • Sell Aurobindo Pharma, target Rs 627: Rudra Shares

    Stock is facing resistance of declining trend line. On daily chart stock has started trading below important moving averages.

  • Buy Aurobindo Pharma, target Rs 950: Aditya Agarwala

    The stock may be bought in the range of Rs 820-825 for targets of Rs 900-950, keeping a stop loss below Rs 770, says Aditya Agarwala of YES Securities.

  • Technical Views | Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com recommends selling Axis Bank with stop loss at Rs 627 and target of Rs 614, Syndicate Bank with stop loss at Rs 35.70 and target of Rs 33.30 and Jain Irrigation Systems with stop loss at Rs 67.05 and target of Rs 63.40.

  • Pharma stocks poised for a bounceback; 3 bets for over 20% returns

    In coming week any tick above 9,350 on Nifty Pharma index will trigger fresh buying in pharma stocks, Arpan Shah of Monarch Networth Capital said

  • These 3 Indian pharma firms to benefit from warning letter to Mylan's US facility

    The slowdown in production at Morgantown site could provide a window of opportunity to Mylan's peers

  • Technical Views | Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com suggests buying Dabur India with stop loss at Rs 395 and target of Rs 419, Aurobindo Pharma with stop loss at Rs 779 and target of Rs 822 and MRF with stop loss at Rs 67000 and target of Rs 69500.

  • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying Titan Company with a stop loss of Rs 920, target of Rs 945, Ajanta Pharma with a stop loss of Rs 1130, target of Rs 1165 and Bajaj Finance with a stop loss of Rs 2400, target of Rs 2520.

  • Buy Aurobindo Pharma, target Rs 900: Ashish Chaturmohta

    The stock can be bought at the current level and on dips to Rs 780 with a stop loss below Rs 755 for a target of Rs 900, says Ashish Chaturmohta of Sanctum Wealth Management.

  • Nifty must sustain above 10,850 for rally towards 11,090; RIL among Sanctum's top 5 bets

    Further rise in VIX is likely cap the gains in markets and trade in a range. VIX needs to move lower for market to move higher, says Ashish Chaturmohta of Sanctum Wealth Management.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347